Bone R, Sampson N S, Bartlett P A, Agard D A
Department of Biochemistry and Biophysics, University of California, San Francisco 94143-0448.
Biochemistry. 1991 Feb 26;30(8):2263-72. doi: 10.1021/bi00222a032.
The structures of the complexes with alpha-lytic protease of both phosphorus stereoisomers of N-[(2S)-2-[[[(1R)-1-[N-[(tert-butyloxycarbonyl)-L-alanyl-L-alanyl- L-prolyl]amino]-2-methylpropyl]-phenoxyphosphinyl]oxy]propanoyl]- L-alanine methyl ester, an analogue of the peptide Boc-Ala-Ala-Pro-Val-Ala-Ala where Val is replaced with an analogous phosphonate phenyl ester and the subsequent Ala is replaced with lactate, have been determined to high resolution (1.9 A) by X-ray crystallography. Both stereoisomers inactivate the enzyme but differ by a factor of 2 in the second-order rate constant for inactivation [Sampson, N. S., & Bartlett, P. A. (1991) Biochemistry (preceding paper in this issue)]. One isomer (B) forms a tetrahedral adduct in which the phosphonate phenyl ester is displaced by the active site serine (S195) and interacts with the enzyme across seven substrate recognition sites that span both sides of the scissile bond. Seven hydrogen bonds are formed with the enzyme, and 510 A2 of hydrophobic surface area is buried when the inhibitor interacts with the enzyme. Although two hydrogen bonds are gained by incorporation of two residues on the C-terminal side of the scissile bond into the inhibitor, there is very little adjustment in the structure of the enzyme in this region. Surprisingly, the active site histidine (H57) does not interact with the phosphonate, apparently because the phosphonate lacks negative charge in or near the oxyanion hole, and instead, the side chain rotates out of the active site cleft and hydrogen bonds with solvent. The other isomer (A) forms a mixture of two different tetrahedral adducts in the active site, both covalently bonded to Ser 195. One adduct, at approximately 58% occupancy, is exactly the same in structure as the complex formed with isomer B, and the other adduct, at 42% occupancy, has lost the two residues C-terminal to the scissile bond by hydrolysis. In the lower occupancy structure, His 57 does not rotate out of the active site and forms a hydrogen bond with the phosphonate oxygen instead. The structures of both complexes were insensitive to pH. As very little change in structure accompanies the histidine rotation, the complex with isomer B provides an excellent mimic for the structure of the transition state (or high-energy reaction intermediate) that spans both sides of the scissile bond.
N-[(2S)-2-[[[(1R)-1-[N-[(叔丁氧羰基)-L-丙氨酰-L-丙氨酰-L-脯氨酰]氨基]-2-甲基丙基]-苯氧基膦酰基]氧基]丙酰基]-L-丙氨酸甲酯是肽Boc-Ala-Ala-Pro-Val-Ala-Ala的类似物,其中Val被类似的膦酸苯酯取代,随后的Ala被乳酸取代。通过X射线晶体学已将其两种磷立体异构体与α-溶血型蛋白酶形成的复合物结构解析到高分辨率(1.9 Å)。两种立体异构体均使该酶失活,但失活的二级速率常数相差2倍[Sampson, N. S., & Bartlett, P. A. (1991) Biochemistry(本期前一篇论文)]。一种异构体(B)形成四面体加合物,其中膦酸苯酯被活性位点丝氨酸(S195)取代,并通过跨越可裂解键两侧的七个底物识别位点与酶相互作用。与酶形成了七个氢键,当抑制剂与酶相互作用时,有510 Ų的疏水表面积被掩埋。尽管通过将可裂解键C端侧的两个残基并入抑制剂中获得了两个氢键,但该区域的酶结构几乎没有调整。令人惊讶的是,活性位点组氨酸(H57)不与膦酸酯相互作用,显然是因为膦酸酯在氧负离子孔内或附近缺乏负电荷,相反,其侧链旋转出活性位点裂隙并与溶剂形成氢键。另一种异构体(A)在活性位点形成两种不同四面体加合物的混合物,两者均与Ser 195共价结合。一种加合物的占有率约为58%,其结构与异构体B形成的复合物完全相同,另一种加合物的占有率为42%,已通过水解失去了可裂解键C端的两个残基。在占有率较低的结构中,His 57不会旋转出活性位点,而是与膦酸酯氧形成氢键。两种复合物的结构对pH均不敏感。由于组氨酸旋转时结构变化很小,与异构体B形成的复合物为跨越可裂解键两侧的过渡态(或高能反应中间体)结构提供了极好的模拟。